FIELD: medicine.
SUBSTANCE: invention relates to new compounds of C-mannoside of the formula I or their pharmaceutically acceptable salts, which have inhibitory activity relatively to FimH. In the formula I, R1 is CH3 or CF3; R2 is H; R3 is F; R4 is CH3, Cl, Br, vinyl, CF3, F, or H; R5 is F or H; and R6 is H. The invention also relates to a pharmaceutical composition, including for local and oral administration, containing a compound of the formula I, a method for inhibition of FimH function, and a method for treatment of FimH-mediated disease.
EFFECT: obtainment of a compound for the treatment of urinary tract infections.
28 cl, 2 tbl, 110 ex
Title | Year | Author | Number |
---|---|---|---|
MANNOSE DERIVATIVES FOR TREATING BACTERIAL INFECTIONS | 2014 |
|
RU2678327C2 |
SECONDARY MANNOSIS FOR BACTERIAL INFECTIONS TREATMENT | 2013 |
|
RU2667060C2 |
METHOD FOR PRODUCING DEPHENYLMETHANE DERIVATIVE | 2017 |
|
RU2797392C2 |
METHOD OF PRODUCING DEPHENYLMETHANE DERIVATIVE | 2023 |
|
RU2814846C1 |
β-LACTAMS, METHOD FOR PREPARING INDICATED COMPOUNDS AND SERUM HYPOCHOLESTEROLEMIC AGENTS CONTAINING SUCH COMPOUNDS | 2002 |
|
RU2301799C2 |
N-(2-CYANO HETEROCYCLYL)PYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS | 2014 |
|
RU2669922C2 |
THIONUCLEOSIDE DERIVATIVE OR SALT THEREOF AND PHARMACEUTICAL COMPOSITION | 2015 |
|
RU2669806C1 |
TLR7 AGONISTS | 2019 |
|
RU2817014C2 |
AZULENE DERIVATIVE, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR TREATMENT OF DIABETES MELLITUS | 2003 |
|
RU2295522C2 |
BENZYLPHENYLCYCLOHEXANE DERIVATIVES AND METHODS OF THEREOF APPLICATION | 2008 |
|
RU2505521C2 |
Authors
Dates
2023-02-15—Published
2019-07-08—Filed